Changmao Biochemical Engineering (HKG:0954) reported 25.8 million yuan in attributable loss for the half ended June 30, widening from 18.8 million yuan a year earlier, according to a Hong Kong bourse filing Monday.
Loss per share was 0.049 yuan, compared with 0.035 in the prior year.
Revenue fell 13% year-on-year to 272.3 million yuan, figures showed.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.